Jagsonpal Pharmaceuticals informs about change in KMPs

16 Jul 2022 Evaluate

Jagsonpal Pharmaceuticals has informed that the Board of Directors at their meeting held today has approved changes in KMPs authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to stock exchange(s) under the SEBI LODR. The contact details of the KMPs authorized is enclosed.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

340.55 4.10 (1.22%)
28-May-2024 15:31 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1464.85
Dr. Reddys Lab 5955.65
Cipla 1477.15
Zydus Lifesciences 1050.35
Lupin 1603.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.